Nieuws

ONCURIOUS NV, a Belgium-based biotech company focused on developing innovative oncology treatments designed to enhance T cell migration, infiltration and activity into resistant tumour sites, today reports the publication of a paper in the Journal for Immunotherapy of Cancer.

Each year, the EU launches calls for postdoc research fellowships through the Marie Sklodowska-Curie Actions. The prestigious two-year funding of Marie Curie fellowships attracts an enormous number of applications, which makes these fellowships very competitive.